Lv42
440 积分 2025-06-05 加入
MK-0457, an Aurora kinase and BCR–ABL inhibitor, is active in patients with BCR–ABL T315I leukemia
2个月前
已完结
Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferase
4个月前
已完结
Recent Progress in DNA Damage Response-Targeting PROTAC Degraders
5个月前
已完结
Design and Application of Cereblon-Recruiting Prodegraders
6个月前
已完结
皖公网安备34019202002308
